Investing
CapEx
Roivant Sciences CapEx decreased by 83.9% to $1.26M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.5%, from $811.00K to $1.26M. Over 3 years (FY 2021 to FY 2024), CapEx shows a downward trend with a -35.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
Detailed definition
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Peer comparison
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
Metric ID:
capital_expendituresHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.34M | $2.76M | $6.07M | $6.26M | $7.46M | $3.10M | $508.00K | $1.62M | $403.00K | $275.00K | $355.00K | $349.00K | $965.00K | $996.00K | $1.83M | $811.00K | $4.04M | $7.85M | $1.26M |
| QoQ Change | — | +18.0% | +120.0% | +3.1% | +19.1% | -58.4% | -83.6% | +219.3% | -75.2% | -31.8% | +29.1% | -1.7% | +176.5% | +3.2% | +83.4% | -55.6% | +397.5% | +94.5% | -83.9% |
| YoY Change | — | — | — | — | +218.9% | +12.3% | -91.6% | -74.1% | -94.6% | -91.1% | -30.1% | -78.5% | +139.5% | +262.2% | +414.6% | +132.4% | +318.1% | +688.0% | +55.5% |
Range$275.00K – $7.85M
CAGR-12.8%
Avg YoY Growth+118.8%
Median YoY Growth+55.5%
CapEx at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's capex?
- Roivant Sciences (ROIV) reported capex of $1.26M in Q1 2026.
- How has Roivant Sciences's capex changed year-over-year?
- Roivant Sciences's capex increased by 55.5% year-over-year, from $811.00K to $1.26M.
- What is the long-term trend for Roivant Sciences's capex?
- Over 3 years (2021 to 2024), Roivant Sciences's capex has grown at a -35.9% compound annual growth rate (CAGR), from $17.44M to $4.60M.
- What does capex mean?
- Cash spent on purchasing or maintaining physical assets like machinery and facilities.